Use of extracorporeal membrane oxygenation in adults.
暂无分享,去创建一个
Gökhan Lafç | A. Budak | A. Yener | O. Çiçek | Gökhan Lafç | Ali Baran Budak | Ali Ümit Yener | Omer Faruk Cicek
[1] M. Senni,et al. Reduction of Haemorrhagic Complications during Mechanically Assisted Circulation with the Use of a Multi-System Anticoagulation Protocol , 1995, The International journal of artificial organs.
[2] A. Goldman,et al. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[3] M. Stroud,et al. Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus* , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[4] Duncan Macrae,et al. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation , 1996, The Lancet.
[5] J. Arnold,et al. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. , 2003, Journal of pediatric surgery.
[6] Michael Quintel,et al. Extracorporeal membrane oxygenation , 2005, Current opinion in critical care.
[7] N. Smedira,et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. , 2001, The Journal of thoracic and cardiovascular surgery.
[8] C. Festen,et al. Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. , 1997, Journal of pediatric surgery.
[9] E. Spitznagel,et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.
[10] C. Foroulis,et al. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. , 2003, The Annals of thoracic surgery.
[11] E. Fosse,et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.
[12] P. Rycus,et al. Extracorporeal Life Support Registry Report 2004 , 2005, ASAIO journal.
[13] J. Beca,et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1--overview of extracorporeal membrane oxygenation. , 2009, Journal of cardiothoracic and vascular anesthesia.
[14] R. Bartlett,et al. Significant safety advantages gained with an improved pressure-regulated blood pump. , 1996, The journal of extra-corporeal technology.
[15] N. Smedira,et al. Mechanical circulatory assistance: state of art. , 2002, Circulation.
[16] M. Adams,et al. Veno-arterial extracorporeal membrane oxygenation for high-risk cardiac catheterisation procedures. , 2010, Heart, lung & circulation.
[17] S. Marasco,et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. , 2008, Heart, lung & circulation.
[18] T. Motomura,et al. Development of silicone rubber hollow fiber membrane oxygenator for ECMO. , 2003, Artificial organs.
[19] P. Betit. Extracorporeal membrane oxygenation: quo vadis? , 2009, Respiratory care.
[20] R. Hetzer,et al. Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. , 2007, The Annals of thoracic surgery.
[21] J. Hirsh,et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.
[22] W. Oliver. Anticoagulation and Coagulation Management for ECMO , 2009, Seminars in cardiothoracic and vascular anesthesia.
[23] G. Patterson,et al. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. , 2002, The Journal of thoracic and cardiovascular surgery.
[24] E. Fosse,et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.
[25] D. Cohn,et al. Analysis of microembolic particles originating in extracorporeal circuits , 1987 .
[26] A. Pesenti,et al. Extracorporeal carbon dioxide removal (ECCO2R): a new form of respiratory assistance. , 1979, The International journal of artificial organs.
[27] Peter Kleine,et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. , 2008, The Journal of thoracic and cardiovascular surgery.
[28] J. Fortenberry,et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure* , 2003, Pediatric Critical Care Medicine.
[29] G. Gravlee,et al. Cardiopulmonary Bypass: Principles and Practice , 2000 .
[30] G. Nuttall,et al. Efficacy of a Simple Intraoperative Transfusion Algorithm for Nonerythrocyte Component Utilization after Cardiopulmonary Bypass , 2001, Anesthesiology.
[31] W. Ko,et al. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. , 2002, The Annals of thoracic surgery.
[32] Vivek Trikha,et al. Clinical Study , 1961, Acta neurologica Scandinavica.
[33] E. Fosse,et al. Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit , 1996, Perfusion.
[34] K. Mellgren,et al. Induced cell trauma during in vitro perfusion: a comparison between two different perfusion systems. , 1998, Artificial organs.
[35] A. Ündar,et al. Use of a Novel Anticoagulation Strategy During ECMO in a Pediatric Population: Single-Center Experience. , 2006, ASAIO journal.
[36] R. Bartlett,et al. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] Rolf Rossaint,et al. Extracorporeal gas exchange with the DeltaStream rotary blood pump in experimental lung injury. , 2003, Artificial organs.
[38] R. Bartlett,et al. A toroidal flow membrane oxygenator: four day partial bypass in dogs. , 1969, Surgical forum.
[39] T. Boes,et al. Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange , 2006, Intensive Care Medicine.
[40] N. Chi,et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue* , 2006, Critical care medicine.
[41] Takaaki Suzuki. Additional lung-protective perfusion techniques during cardiopulmonary bypass. , 2010, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[42] N. Doll,et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. , 2010, The Journal of thoracic and cardiovascular surgery.
[43] J. Tobis,et al. Subacute stent thrombosis associated with a heparin‐coated stent and heparin‐induced thrombocytopenia , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[44] S. Renolleau,et al. Venovenous single lumen cannula extracorporeal lung support in neonates. A five year experience. , 1993, ASAIO journal (1992).
[45] J J Osborn,et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.
[46] M. Gruber,et al. In Vivo Uptake and Elimination of Isoflurane by Different Membrane Oxygenators during Cardiopulmonary Bypass , 2002, Anesthesiology.
[47] J. Svennevig,et al. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation , 2007, Perfusion.
[48] X. Hou,et al. Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. , 2009, The Annals of thoracic surgery.
[49] E. Spitznagel,et al. More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT , 1996, Thrombosis and Haemostasis.
[50] Pearson Dt. Gas exchange: bubble and membrane oxygenators. , 1990, Seminars in thoracic and cardiovascular surgery.
[51] J. Dhainaut,et al. Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal , 2005, Intensive Care Medicine.
[52] R. Bartlett,et al. A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support. , 1998, The Journal of thoracic and cardiovascular surgery.
[53] G. Peek,et al. Early Experience with a Polymethyl Pentene Oxygenator for Adult Extracorporeal Life Support , 2002, ASAIO journal.
[54] A. Sosnowski,et al. Poly-Methyl Pentene Oxygenators Have Improved Gas Exchange Capability and Reduced Transfusion Requirements in Adult Extracorporeal Membrane Oxygenation , 2005, ASAIO journal.
[55] G Wright,et al. Mechanical simulation of cardiac function by means of pulsatile blood pumps. , 1997, Journal of cardiothoracic and vascular anesthesia.
[56] A. Vuylsteke,et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. , 2008, The Annals of thoracic surgery.
[57] R. Bartlett,et al. Blood activation during neonatal extracorporeal life support , 1993 .
[58] D. S. Lawson,et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. , 2004, The journal of extra-corporeal technology.
[59] N. Doll,et al. Autopsy Findings in Patients on Postcardiotomy Extracorporeal Membrane Oxygenation (ECMO) , 2006, The International journal of artificial organs.
[60] J. O'Neill,et al. Nosocomial infections during extracorporeal membrane oxygenation , 2001, Intensive Care Medicine.
[61] Robert H. Bartlett,et al. Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in Adults , 2004, Annals of surgery.
[62] Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. , 1979 .
[63] C. Tribble,et al. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. , 2001, The Annals of thoracic surgery.
[64] P. Venge,et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. , 1992, The Journal of thoracic and cardiovascular surgery.
[65] P. Albertsson,et al. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. , 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[66] J. Beca,et al. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. , 2010, Journal of cardiothoracic and vascular anesthesia.
[67] D. S. Lawson,et al. Hemolytic characteristics of three commercially available centrifugal blood pumps , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[68] A. Pesenti,et al. Adult Respiratory Distress Syndrome (Ards): Why Did Ecmo Fail? , 1981, The International journal of artificial organs.
[69] T. Kickler,et al. Effect of extracorporeal membrane oxygenation on platelets in newborns , 1993, Critical care medicine.
[70] E. Fosse,et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. , 1995, The Annals of thoracic surgery.
[71] S. Thelin,et al. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[72] J. Shayevitz,et al. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. , 1996, Journal of cardiothoracic and vascular anesthesia.
[73] R. Bartlett,et al. Use of venovenous extracorporeal membrane oxygenation and an atrial septostomy for pulmonary and right ventricular failure. , 2011, The Annals of thoracic surgery.
[74] E. Fosse,et al. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population. , 1999, The Journal of thoracic and cardiovascular surgery.
[76] C. Coopersmith,et al. Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. , 2008, Chest.
[77] P. McCarthy,et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. , 1996, The Annals of thoracic surgery.
[78] E. Farthmann,et al. Extracorporeal membrane oxygenation: a ten-year experience. , 2000, American journal of surgery.
[79] E. Fosse,et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.
[80] F. Szlam,et al. A Comparison of Heparin Management Strategies in Infants Undergoing Cardiopulmonary Bypass , 2008, Anesthesia and analgesia.
[81] F. Colardyn,et al. The use of the activated clotting time for monitoring heparin therapy in critically ill patients , 2003, Intensive Care Medicine.
[82] Pascal Leprince,et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.
[83] F. Pigula,et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. , 2007, The Annals of thoracic surgery.
[84] S. Allen,et al. Cooling gradients and formation of gaseous microemboli with cardiopulmonary bypass: an echocardiographic study. , 1997, The Annals of thoracic surgery.
[85] BM Leschinsky,et al. Centrifugal blood pumps — a brief analysis: development of new designs , 1991, Perfusion.
[86] A. Mazzucco,et al. Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. , 1999, The Annals of thoracic surgery.
[87] S. Vesconi,et al. TREATMENT OF ACUTE RESPIRATORY FAILURE WITH LOW-FREQUENCY POSITIVE-PRESSURE VENTILATION AND EXTRACORPOREAL REMOVAL OF CO2 , 1980, The Lancet.
[88] W. Muntean,et al. Coagulation and anticoagulation in extracorporeal membrane oxygenation. , 1999, Artificial organs.
[89] W. S. Haworth. The development of the modern oxygenator. , 2003, The Annals of thoracic surgery.
[90] P. Mankad,et al. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice , 2000, Perfusion.
[91] D. Elbourne,et al. UK COLLABORATIVE RANDOMIZED TRIAL OF NEONATAL EXTRACORPOREAL MEMBRANE OXYGENATION , 1997 .
[92] R. Bartlett,et al. Extracorporeal life support. , 2006, Seminars in pediatric surgery.
[93] K. Moser,et al. Surgical management of chronic pulmonary embolism: surgical treatment and late results. , 1980, The Journal of thoracic and cardiovascular surgery.
[94] B. Kiaii,et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.
[95] N. Smedira,et al. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. , 1999, European Journal of Cardio-Thoracic Surgery.
[96] C. Baufreton,et al. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. , 1999, The Annals of thoracic surgery.
[97] Dean F. Sittig,et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. , 1994, American journal of respiratory and critical care medicine.
[98] E. Lehr,et al. Peripheral versus central cannulation for extracorporeal membrane oxygenation: a comparison of limb ischemia and transfusion requirements. , 2010, The Thoracic and cardiovascular surgeon.
[99] Shengshou Hu,et al. Five-year results of 121 consecutive patients treated with extracorporeal membrane oxygenation at Fu Wai Hospital. , 2011, Artificial organs.
[100] G. Schears,et al. Optimal Time for Initiating Extracorporeal Membrane Oxygenation , 2009, Seminars in cardiothoracic and vascular anesthesia.
[101] G. Magovern,et al. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. , 1999, The Annals of thoracic surgery.
[102] W. Buhre,et al. Successful use of a miniaturized bypass system with the DeltaStream extracorporeal rotary blood pump. , 2003, The Journal of thoracic and cardiovascular surgery.
[103] R. Fumagalli,et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. , 1986, JAMA.
[104] M. Ziegler,et al. The significant relationship between platelet count and haemorrhagic complications on ECMO , 1994, Perfusion.
[105] R. Hetzer,et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. , 2000, ASAIO journal.
[106] C. Brizard,et al. Pump-induced haemolysis: a comparison of short-term ventricular assist devices , 2004, Perfusion.
[107] Diana Elbourne,et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial , 2009, The Lancet.